Literature DB >> 29858533

De novo mutations in FLNC leading to early-onset restrictive cardiomyopathy and congenital myopathy.

Artem Kiselev1, Raquel Vaz2, Anastasia Knyazeva1, Aleksandr Khudiakov1, Svetlana Tarnovskaya1,3, Jiao Liu4, Alexey Sergushichev5, Sergey Kazakov5, Dmitrij Frishman3,6, Natalia Smolina1,5,7, Tatiana Pervunina1, John Jorholt7, Gunnar Sjoberg7, Tatiana Vershinina1, Dmitriy Rudenko8, Anders Arner4, Thomas Sejersen7, Anna Lindstrand2,9, Anna Kostareva1,7.   

Abstract

Mutations in FLNC for a long time are known in connection to neuromuscular disorders and only recently were described in association with various cardiomyopathies. Here, we report a new clinical phenotype of filaminopathy in four unrelated patients with early-onset restrictive cardiomyopathy (RCM) in combination with congenital myopathy due to FLNC mutations (NM_001458.4:c.3557C>T, p.A1186V, rs1114167361 in three probands and c.[3547G>C; 3548C>T], p.A1183L, rs1131692185 in one proband). In all cases, concurrent myopathy was confirmed by neurological examination, electromyography, and morphological studies. Three of the patients also presented with arthrogryposis. The pathogenicity of the described missense variants was verified by cellular and morphological studies and by in vivo modeling in zebrafish. Combination of in silico and experimental approaches revealed that FLNC missense variants localized in Ig-loop segments often lead to development of RCM. The described FLNC mutations associated with early-onset RCMP extend cardiac spectrum of filaminopathies and facilitate the differential diagnosis of restrictive cardiac phenotype associated with neuromuscular involvement in children.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiomyopathy; filamin C; mutation; myopathy; zebrafish model

Mesh:

Substances:

Year:  2018        PMID: 29858533     DOI: 10.1002/humu.23559

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

Review 1.  Filamin C in cardiomyopathy: from physiological roles to DNA variants.

Authors:  Shen Song; Anteng Shi; Hong Lian; Shengshou Hu; Yu Nie
Journal:  Heart Fail Rev       Date:  2021-09-17       Impact factor: 4.654

2.  FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling.

Authors:  Anastasia Knyazeva; Aleksandr Khudiakov; Raquel Vaz; Aleksey Muravyev; Ksenia Sukhareva; Thomas Sejersen; Anna Kostareva
Journal:  Genes (Basel)       Date:  2020-11-13       Impact factor: 4.096

Review 3.  Molecular mechanisms of arrhythmogenic cardiomyopathy.

Authors:  Karyn M Austin; Michael A Trembley; Stephanie F Chandler; Stephen P Sanders; Jeffrey E Saffitz; Dominic J Abrams; William T Pu
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

4.  The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy".

Authors:  Julia Schuld; Peter F M van der Ven; Anne Schänzer; Elisabeth Schumann; Diana Zengeler; Lisann Gulatz; Giovanni Maroli; Uwe Ahting; Anke Sprengel; Sabine Gräf; Andreas Hahn; Christian Jux; Till Acker; Dieter O Fürst; Stefan Rupp
Journal:  J Muscle Res Cell Motil       Date:  2021-03-12       Impact factor: 2.698

5.  Neurogenetic fetal akinesia and arthrogryposis: genetics, expanding genotype-phenotypes and functional genomics.

Authors:  Gina Ravenscroft; Joshua S Clayton; Fathimath Faiz; Padma Sivadorai; Di Milnes; Rob Cincotta; Phillip Moon; Ben Kamien; Matthew Edwards; Martin Delatycki; Phillipa J Lamont; Sophelia Hs Chan; Alison Colley; Alan Ma; Felicity Collins; Lucinda Hennington; Teresa Zhao; George McGillivray; Sondhya Ghedia; Katherine Chao; Anne O'Donnell-Luria; Nigel G Laing; Mark R Davis
Journal:  J Med Genet       Date:  2020-10-15       Impact factor: 6.318

Review 6.  Recent advances in understanding congenital myopathies.

Authors:  Gianina Ravenscroft; Robert J Bryson-Richardson; Kristen J Nowak; Nigel G Laing
Journal:  F1000Res       Date:  2018-12-11

7.  Molecular autopsy: using the discovery of a novel de novo pathogenic variant in the KCNH2 gene to inform healthcare of surviving family.

Authors:  Jingyun Dong; Nori Williams; Marina Cerrone; Christopher Borck; Dawei Wang; Bo Zhou; Lucy S Eng; Ekaterina Subbotina; Sung Yon Um; Ying Lin; Kevin Ruiter; Lisa Rojas; William A Coetzee; Barbara A Sampson; Yingying Tang
Journal:  Heliyon       Date:  2018-12-08

Review 8.  Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.

Authors:  Andreas Brodehl; Hans Ebbinghaus; Marcus-André Deutsch; Jan Gummert; Anna Gärtner; Sandra Ratnavadivel; Hendrik Milting
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

9.  Clinical exome sequencing revealed that FLNC variants contribute to the early diagnosis of cardiomyopathies in infant patients.

Authors:  Feifan Xiao; Qiufen Wei; Bingbing Wu; Xu Liu; Aiyao Mading; Lin Yang; Yan Li; Fang Liu; Xinnian Pan; Huijun Wang
Journal:  Transl Pediatr       Date:  2020-02

10.  A mutation update for the FLNC gene in myopathies and cardiomyopathies.

Authors:  Job A J Verdonschot; Els K Vanhoutte; Godelieve R F Claes; Apollonia T J M Helderman-van den Enden; Janneke G J Hoeijmakers; Debby M E I Hellebrekers; Amber de Haan; Imke Christiaans; Ronald H Lekanne Deprez; Hanne M Boen; Emeline M van Craenenbroeck; Bart L Loeys; Yvonne M Hoedemaekers; Carlo Marcelis; Marlies Kempers; Esther Brusse; Jaap I van Waning; Annette F Baas; Dennis Dooijes; Folkert W Asselbergs; Daniela Q C M Barge-Schaapveld; Pieter Koopman; Arthur van den Wijngaard; Stephane R B Heymans; Ingrid P C Krapels; Han G Brunner
Journal:  Hum Mutat       Date:  2020-03-20       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.